Featured Press Releases
Biotechnology
-
Stratedigm announces the launch of the A600 High Throughput Auto Sampler with Flat-6 Technology TM
/EINPresswire.com/San Jose, CA., March 3, 2012- Stratedigm announces the commercial launch of its A600 High Throughput Auto Sampler (HTAS). The A600 HTAS compliments the company's existing line of analyzers which range from the entry level...
-
BiOZEEN APPOINTS MAHADEVAN AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
BiOZEEN APPOINTS MAHADEVAN AS PRESIDENT &CHIEF EXECUTIVE OFFICER Industry leader and former Merck Millipore Executive tapped as the President &CEO of the only company in the Industry Integrating equipment manufacturing, consultancy and training...
-
TCT Receives Patent on Small Molecule for Treating Multiple Cancer Types
/EINPresswire.com/ SANTA ROSA, CA (2/14/12) --Targeted Cancer Therapeutics LLC (TCT) announced that its Nucleophosmin 1 (NPM1) inhibitor, NSC348884, received the U.S. Designation of Patent Number 8,063,089. The patent claims allow for a method...
-
Go!Foton Announces the Availability of Fluorescence Micro-Optics for Instrument Makers
/EINPresswire.com/ Go!Foton expands its industry-leading offering in fiber-optic fluorescence detection technology with the availability of micro-optical heads to makers of analytical instruments. Somerset, New Jersey - Leveraging upon the...
-
EIN News Launches Celgene Daily Report
Washington, January 25, 2012 /EINPresswire.com/ EIN News, a leading media monitoring company since 1995, has announced the launch of Celgene Daily Report. For more news see: - Celgene Foundations News - http://celgene.einnews.com/news/celgene-foundations -...
-
Amarantus BioSciences Licenses Disease Diagnostic Biomarker Test from Power3 Medical Products
Amarantus BioSciences Licenses Parkinson's Disease Diagnostic Biomarker Test from Power3 Medical Products /EINPresswire.com/ SUNNYVALE, CA and THE WOODLANDS, TX - January 23, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology...
-
Amarantus BioSciences Interview at the 2012 Biotech Showcase
/EINPresswire.com/ SUNNYVALE, CA - January 20, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, was interviewed at the 2012 Biotech Showcase in...
-
TCT Receives Patent on Therapeutic Monoclonal Antibody Targeting Pancreatic Cancer
/EINPresswire.com/ SANTA ROSA, CA, (1/18/12) --Targeted Cancer Therapeutics LLC (TCT) announced that its anti-CEACAM6 product received the U.S. Designation of Patent Number 8,038,996. The patent claims allow for a method of treating various...
-
Geron Corporation Daily Report Launched by EIN News
Washington, January 16, 2012 /EINPresswire.com/ EIN News, a leading media monitoring company published by the IPD Group, has announced the launch of Geron Corporation Daily Report. For more details see: - Geron Biotechnology News - http://geron.einnews.com/news/geron-biotechnology -...
-
Genzyme Daily Report Launched by EIN News
Washington, January 13, 2012 /EINPresswire.com/ EIN News, a leading media monitoring company published by the IPD Group, has announced the launch of Genzyme Daily Report. For more details see: - Genzyme Genetics News - http://genzyme.einnews.com/news/genzyme-genetics -...
-
Amarantus BioSciences to be Interviewed on The Big Biz Radio Show
/EINPresswire.com/SUNNYVALE, CA - January 12, 2012 - Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today announced the company will be a featured guest...
-
the challenges associated with obtaining an optimal pharmaceutical portfolio of projects.
SMi presents their 7th annual conference on... Pharmaceutical Portfolio & Product Lifecycle Management 18th-19th April 2012, The Grange Holborn Hotel, London, United Kingdom /EINPresswire.com/ With declining R&D costs, prioritizing a portfolio...
-
How to best standardise imaging result from multi centre clinical trials
SMi present their 8th annual conference on......... Imaging in Cancer Drug Development 14-15 March 2012, Copthorne Tara Hotel, London /EINPresswire.com/ The number of patients diagnosed with cancer worldwide each year is estimated to be...
-
Amarantus BioSciences Releases New Video Interview with President and CEO Gerald Commissiong
/EINPresswire.com/ Amarantus BioSciences Inc. (OTCBB: AMBS) is a biopharmaceutical company that has discovered a revolutionary therapeutic protein that could change the way many major diseases are treated. Recently, the biotech company released...
-
Amarantus BioSciences Updates Shareholders on Execution of Expanded Corporate Strategy
/EINPresswire.com/ SUNNYVALE, Calif. Amarantus BioSciences, Inc. (OTCBB: AMBS.OB - News), a biotechnology company developing MANF, a first-in-class disease-modifying therapeutic protein, today provided shareholders with an update on the execution...
Follow us
What people say
Our Partners
© 2005-2012